Does VEDOLIZUMAB Cause Inappropriate schedule of product administration? 3,259 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 3,259 reports of Inappropriate schedule of product administration have been filed in association with VEDOLIZUMAB (ENTYVIO). This represents 4.4% of all adverse event reports for VEDOLIZUMAB.
3,259
Reports of Inappropriate schedule of product administration with VEDOLIZUMAB
4.4%
of all VEDOLIZUMAB reports
70
Deaths
828
Hospitalizations
How Dangerous Is Inappropriate schedule of product administration From VEDOLIZUMAB?
Of the 3,259 reports, 70 (2.1%) resulted in death, 828 (25.4%) required hospitalization, and 38 (1.2%) were considered life-threatening.
Is Inappropriate schedule of product administration Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for VEDOLIZUMAB. However, 3,259 reports have been filed with the FAERS database.
What Other Side Effects Does VEDOLIZUMAB Cause?
Off label use (21,017)
Colitis ulcerative (13,455)
Crohn's disease (9,759)
Drug ineffective (8,424)
Diarrhoea (7,493)
Abdominal pain (6,401)
Fatigue (5,477)
Haematochezia (5,215)
Frequent bowel movements (4,527)
Arthralgia (4,028)
What Other Drugs Cause Inappropriate schedule of product administration?
ADAPALENE (16,473)
DUPILUMAB (14,927)
AVOBENZONE\OCTISALATE\OCTOCRYLENE (12,546)
INSULIN GLARGINE (8,982)
INFLIXIMAB (6,847)
INFLIXIMAB-DYYB (5,977)
SECUKINUMAB (4,817)
DULAGLUTIDE (3,606)
SACUBITRIL\VALSARTAN (2,870)
ACETAMINOPHEN (2,248)
Which VEDOLIZUMAB Alternatives Have Lower Inappropriate schedule of product administration Risk?
VEDOLIZUMAB vs VELAGLUCERASE ALFA
VEDOLIZUMAB vs VELCADE
VEDOLIZUMAB vs VELETRI
VEDOLIZUMAB vs VELIPARIB
VEDOLIZUMAB vs VEMURAFENIB